Literature DB >> 1338214

[A case of Fabry's disease associated with lupus nephritis].

K Majima1, T Ishizaki, T Inoue, Y Hori, J Egami, A Oohara, H Nishida, Y Miyake, S Matsumoto, E Kinoshita.   

Abstract

A 36-year-old woman was hospitalized because of nephrotic syndrome. On admission, laboratory studies revealed total protein 5.9g/dl, total cholesterol 381mg/dl, urine protein 2-4g/day, C3 68mg/dl(90-185mg/dl) and the immunological tests showed that antinuclear factor, anti-DNA antibodies and the LE cell phenomenon were positive. Renal function was within normal range. After admission, renal biopsy was done. Light microscopic finding showed diffuse membranous glomerulonephritis, and vacuolization of epithelial cells. Immunofluorescent microscopic finding showed a granular specific staining for IgG, IgM, C3 and C1q along the capillary loops. Electron microscopic finding showed subepithelial and subendothelial dense deposits, and visceral epithelial cell cytoplasm containing osmiophilic multilamellar lipoid bodies. In the studies of the enzyme activities, the patient's fibroblast extract demonstrated a partial deficiency of alpha-galactosidase, and urine ceramide trihexoside was positive. But the patient's leukocyte extract did not demonstrate a deficiency of alpha-galactosidase. So Fabry's disease associated with lupus nephritis was diagnosed. It seems that the case of Fabry's disease which is an X-linked disorder caused by deficiency of the lysosomal enzyme alpha-galactosidase, associated with lupus nephritis, is extremely rare.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338214

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  8 in total

1.  Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

Authors:  C Whybra; C Kampmann; I Willers; J Davies; B Winchester; J Kriegsmann; K Brühl; A Gal; S Bunge; M Beck
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

2.  IgA nephropathy in two adolescent sisters heterozygous for Fabry disease.

Authors:  Catharina Whybra; Andreas Schwarting; Jörg Kriegsmann; Andreas Gal; Eugen Mengel; Christoph Kampmann; Frank Baehner; Ellen Schaefer; Michael Beck
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

3.  [Fabry's disease, glomerulonephritis with crescentic and granulomatous interstitial nephritis. Case of one family].

Authors:  J Kriegsmann; M Otto; E Wandel; A Schwarting; J Faust; T Hansen; J Beck; C Whybra; M Beck
Journal:  Pathologe       Date:  2003-10       Impact factor: 1.011

4.  Screening for Fabry Disease in Patients With Juvenile Systemic Lupus Erythematosus.

Authors:  Ertugrul Kiykim; Sezgin Şahİn; Tanyel ZubarioĞlu; Kenan Barut; Amra Adrovic; Mehmet Şerif Cansever; Ayşe Çiğdem AktuĞlu Zeybek; Özgür KasapÇopur
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

5.  Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review.

Authors:  Hironobu Fujisawa; Yosuke Nakayama; Shoichiro Nakao; Ryo Yamamoto; Yuka Kurokawa; Nao Nakamura; Akiko Nagata; Takahiro Tsukimura; Tadayasu Togawa; Hitoshi Sakuraba; Kei Fukami
Journal:  BMC Nephrol       Date:  2019-12-17       Impact factor: 2.388

6.  The coincidence of IgA nephropathy and Fabry disease.

Authors:  Dita Maixnerová; Vladimír Tesař; Romana Ryšavá; Jana Reiterová; Helena Poupětová; Lenka Dvořáková; Lubor Goláň; Michaela Neprašová; Jana Kidorová; Miroslav Merta; Eva Honsová
Journal:  BMC Nephrol       Date:  2013-01-11       Impact factor: 2.388

7.  Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Authors:  A Nandagudi; E C Jury; D Alonzi; T D Butters; S Hughes; D A Isenberg
Journal:  Lupus       Date:  2013-07-17       Impact factor: 2.911

8.  Sudden onset of nephrotic syndrome in an asymptomatic Fabry patient: a case report.

Authors:  Ruixiao Zhang; Zeqing Chen; Yanhua Lang; Shihong Shao; Yan Cai; Qingqing You; Yan Sun; Sai Wang; Xiaomeng Shi; Zhiying Liu; Wencong Guo; Yue Han; Leping Shao
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.